N-[1-[7-(8-ethynyl-7-fluoro-3-hydroxynaphthalen-1-yl)-8-fluoro-2-[[(2S,4R)-4-fluoro-2-methyl-1-[4-[(3S)-3-methylmorpholin-4-yl]cyclohexyl]pyrrolidin-2-yl]methoxy]pyrido[4,3-d]pyrimidin-4-yl]azepan-3-yl]prop-2-enamide
C45H52F3N7O4 — CID 175815582
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-[7-(8-ethynyl-7-fluoro-3-hydroxynaphthalen-1-yl)-8-fluoro-2-[[(2S,4R)-4-fluoro-2-methyl-1-[4-[(3S)-3-methylmorpholin-4-yl]cyclohexyl]pyrrolidin-2-yl]methoxy]pyrido[4,3-d]pyrimidin-4-yl]azepan-3-yl]prop-2-enamide
N-[1-[7-(8-ethynyl-7-fluoro-3-hydroxynaphthalen-1-yl)-8-fluoro-2-[[(2S,4R)-4-fluoro-2-methyl-1-[4-[(3S)-3-methylmorpholin-4-yl]cyclohexyl]pyrrolidin-2-yl]methoxy]pyrido[4,3-d]pyrimidin-4-yl]azepan-3-yl]prop-2-enamide (PubChem CID 175815582) has the molecular formula C45H52F3N7O4 and a molecular weight of 811.95 g/mol. Its IUPAC name is N-[1-[7-(8-ethynyl-7-fluoro-3-hydroxynaphthalen-1-yl)-8-fluoro-2-[[(2S,4R)-4-fluoro-2-methyl-1-[4-[(3S)-3-methylmorpholin-4-yl]cyclohexyl]pyrrolidin-2-yl]methoxy]pyrido[4,3-d]pyrimidin-4-yl]azepan-3-yl]prop-2-enamide.
Molecular Properties
| Compound Name | N-[1-[7-(8-ethynyl-7-fluoro-3-hydroxynaphthalen-1-yl)-8-fluoro-2-[[(2S,4R)-4-fluoro-2-methyl-1-[4-[(3S)-3-methylmorpholin-4-yl]cyclohexyl]pyrrolidin-2-yl]methoxy]pyrido[4,3-d]pyrimidin-4-yl]azepan-3-yl]prop-2-enamide |
|---|---|
| PubChem CID | 175815582 |
| Molecular Formula | C45H52F3N7O4 |
| Molecular Weight | 811.95 g/mol |
| Exact Mass | 811.40 |
| IUPAC Name | N-[1-[7-(8-ethynyl-7-fluoro-3-hydroxynaphthalen-1-yl)-8-fluoro-2-[[(2S,4R)-4-fluoro-2-methyl-1-[4-[(3S)-3-methylmorpholin-4-yl]cyclohexyl]pyrrolidin-2-yl]methoxy]pyrido[4,3-d]pyrimidin-4-yl]azepan-3-yl]prop-2-enamide |
| SMILES | C#Cc1c(F)ccc2cc(O)cc(-c3ncc4c(N5CCCCC(NC(=O)C=C)C5)nc(OC[C@]5(C)C[C@@H](F)CN5C5CCC(N6CCOC[C@@H]6C)CC5)nc4c3F)c12 |
| InChI | InChI=1S/C45H52F3N7O4/c1-5-34-37(47)15-10-28-19-33(56)20-35(39(28)34)41-40(48)42-36(22-49-41)43(53-16-8-7-9-30(24-53)50-38(57)6-2)52-44(51-42)59-26-45(4)21-29(46)23-55(45)32-13-11-31(12-14-32)54-17-18-58-25-27(54)3/h1,6,10,15,19-20,22,27,29-32,56H,2,7-9,11-14,16-18,21,23-26H2,3-4H3,(H,50,57)/t27-,29+,30?,31?,32?,45-/m0/s1 |
| InChIKey | LBDRBRVMJSTEFA-IAYMLEOYSA-N |
| XLogP | 6.68 |
| TPSA | 116.18 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 59 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 811.95 |
| LogP ≤ 5 | 6.68 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175815582 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.